MobiusDick
Bluelighter
Not all monoamines are excitatory.I finally came across an explanation as to why but benzodiazepines can be so psychologically addicting to some people. These studies explained the what/when/how and why of the GABA subtypes and interactions.
Simply put, Benzodiazepines causes a massive disinhibition of Dopamine regulation through binding at the alpha-1 subtype of GABA-a. Even more selective agonists (or PAM agent in this case) could, theoretically explain the adverse side-effects and addiction potential of Zolpidem. Zolpidems highly selective to alpha-1 and likely facilitates over-active expressive repression dipression exertion upon dopaminergic activity. Massive dopamine activity would explain Zolpidems hallucinations and sleep walking. I've always wondered with the amine group of the nitrogen and three carbons on the Zolpidem molecule if it has nAChR or other cholinergic activity.
Anyways, why is all of this? Well here's an excerpt from the study.
Now here's where things get even more interesting. After the findings of the study above we're released, another doctor decided to perform tests on the interaction between benzodiazepines and the alpha-1 subtype of GABAA. These finding found that increased alpha-1 activity caused a massive migration in AMPA receptors located on DA neurons. The expressed AMPA receptors are excitatory to glutamate, and won't actually cause any increase in dopaminergic activity, but will actually cause excitatory repression of synapse cleft surges in dopamine activity effectively suppressing dopamine activity.
I'm looking for a study I once saw on this right this minute, but can't find it at the moment. Will update in a moment.
It appears that while glutamate and monoamine neurotransmitters are both excitatory, monoamines suppress glutamate activity in the mesocorticolimbic reward pathways, and glutamate suppresses monoamine activity in general around the nervous system. Benzodiazepines through GABAergic neurotransmission, suppress glutamatergic activity via calcified ion channel openings and negatively charged chloride ion pathways negating suppression of monoamines. Effectively causing spikes in dopamine activity due to lack of suppression of neurotransmission of glutamate. or "spikes" in monoaminergic activity.
I've yet to see a study on it but my theory is that through nAChR receptor channel activity, chloride ion and calcium ion channel manipulation and other bindings release opioid peptides and causes neurotransmission of dopamine. Speculation I can provide is that some of the antinociceptive activity of benzodiazepines caused by smooth muscle relaxation is the depressing of the muscle due to neuromusclar sedation.
Studies
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013137/pdf/pone.0015870.pdf
doi:10.1038/463743a
http://www.drugabuse.gov/news-event...nderlies-benzodiazepines-addictive-properties
It seems to me that there is not much nicotinic or muscarinic activity related to benzodiazepines themselves although it may be different for Z drugs but I don’t recall those having much of a ACh effect ( n or m). This is unusual for drugs with a secondary or tertiary nitrogen but the 7 membered ring of BZDs may just be too sterically hindered to interact much with the ACh system.
As far as the direct interaction that causes BZDs to be addictive is likely to be the rebound effect related to the chloride channels. GABA-A receptors have that allosteric site for barbiturates that also affects the chloride channels but remains open instead of opens and closes like BZDs. I’ve always found it interesting that there are no antagonists to barbiturates.